ClinicalTrials.Gov: Confidentiality Concerns Are Decreasing, PhRMA Says
Executive Summary
Pharmaceutical manufacturers are becoming more comfortable with the disclosures required on ClinicalTrials.gov as they become more familiar with the system, Pharmaceutical Research & Manufacturers of America Associate VP-Regulatory Affairs Alan Goldhammer, PhD, reports
You may also be interested in...
ClinicalTrials.gov Postings By Industry Increase, But Still Appear Incomplete
The ClinicalTrials.gov database includes over 650 open protocols sponsored by the pharmaceutical industry as of June 17
ClinicalTrials.gov Postings By Industry Increase, But Still Appear Incomplete
The ClinicalTrials.gov database includes over 650 open protocols sponsored by the pharmaceutical industry as of June 17
FDA Launches Phase IV Tracking System; Baseline Is 20% Completion Rate
FDA's Phase IV tracking system shows a 20% completion rate for postmarketing commitments
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: